Biosimilars: patient and physician acceptability is the fifth hurdle to market competition

Alan Lyles

Research output: Contribution to journalLetterpeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Biosimilars: patient and physician acceptability is the fifth hurdle to market competition'. Together they form a unique fingerprint.

Medicine & Life Sciences